Filing Details

Accession Number:
0001209191-23-013685
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-28 16:40:33
Reporting Period:
2023-02-24
Accepted Time:
2023-02-28 16:40:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1550395 David Altshuler C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Global Research And Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-02-24 3,970 $289.12 36,276 No 4 F Direct
Common Stock Disposition 2023-02-27 3,636 $287.23 32,640 No 4 S Direct
Common Stock Disposition 2023-02-27 300 $288.74 32,340 No 4 S Direct
Common Stock Disposition 2023-02-27 302 $289.60 32,038 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
  2. Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  3. Open market sales reported on this line occurred at a weighted average price of $287.23 (range $286.80 to $287.72).
  4. Open market sales reported on this line occurred at a weighted average price of $288.74 (range $288.42 to $289.37).
  5. Open market sales reported on this line occurred at a weighted average price of $289.60 (range $289.49 to $289.65).